• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Genetics

Gene therapy may be helpful for Wiskott-Aldrich Syndrome

byJeffrey CohenandPriyanka Vedak
April 22, 2015
in Genetics, Oncology, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this study of seven individuals with Wiskott-Aldrich Syndrome (WAS), gene therapy improved eczema, susceptibility to infection, autoimmunity, and T cell function.

2. While the presence of WAS protein expressing B cells may indicate an improvement in humoral immune function, the timeframe of the study was too short to fully assess functional outcomes in humoral immunity.

Evidence Rating Level: 3 (Average)   

Study Rundown: Wiskott-Aldrich Syndrome (WAS) is an X-linked primary immunodeficiency that results in bleeding, eczema, susceptibility to infection, autoimmunity, and an increased risk of lymphoid malignancy. While stem cell transplantation can be curative, it can be accompanied by many complications. This study reported on seven patients from England and France with WAS who were treated with gene therapy with a self-inactivating lentivirus vector between December 2010 and January 2014. Autologous hematopoietic stem cells were treated with the lentivirus gene therapy and reinfused after myeloablative conditioning.

Six of seven patients were evaluable for 9 months and those six were all alive and showed clinical improvement in December 2014. Eczema, susceptibility to infections, and autoimmune conditions improved in all cases. There was also evidence of correction of T cell function. The study was too short to assess the functional outcomes in humoral immunity, but the presence of WAS protein expressing B cells may indicate improvement. This study is limited by its small sample size and limited time course. Thus, while this study does suggest that gene therapy may be helpful in individuals with WAS, a larger trial is needed to more completely understand the utility of this therapeutic modality.

Click to read the study, published today in JAMA

Click to read an accompanying editorial, published today in JAMA

RELATED REPORTS

Valoctocogene roxaparvovec gene therapy efficacious for hemophilia A treatment

Betibeglogene autotemcel gene therapy effective for β-thalassemia

Lentiviral gene therapy treatment for adenosine deaminase deficiency

Relevant Reading: Gene therapy for Wiskott-Aldrich syndrome–long-term efficacy and genotoxicity.

In-Depth [prospective cohort]: This study included seven individuals aged 0.8-15.5 years (median 7 years) with WAS who were given a single infusion with lentivirus gene therapy treated CD-34+ from bone marrow (4 cases) or mobilized peripheral blood (3 cases). One month after treatment, vector positive cells were detectable in blood, with 0.35 to 1.20 copies noted in CD3+ T cells, 0.1 to 1.34 in CD19+ B cells, and 0.04 to 0.7 in sorted natural killer CD56+ cells. Six of the seven patients were evaluable 9 months after the intervention and those six individuals were alive and clinically improved December 2014. One patient died of septic shock 7 months after gene therapy after contracting multiple drug resistant opportunistic herpes virus infections. Eczema, susceptibility to infection, and autoimmunity resolved in all study participants. Platelet count and volume improved in 3 individuals but remained low in all participants (mean patient platelet volume ranged 8.1-9.3 fL compared to healthy control platelet volume range of 7.5 to 10.1 fL). T cell function improved with values reaching that of normal absolute T cell counts in most patients. While the presence of WAS protein expressing B cells may signify improved humoral immunity, B cell function was not fully evaluated in 4 of the 6 patients who were still receiving immunoglobulin therapy.

Image: CC/GNU Free

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gene therapywiskott-aldrich
Previous Post

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]

Next Post

PET scans in early-stage Hodgkin’s lymphoma may help guide therapy [RAPID trial]

RelatedReports

New genetic link in pulmonary arterial hypertension holds therapeutic promise
Chronic Disease

Valoctocogene roxaparvovec gene therapy efficacious for hemophilia A treatment

March 21, 2022
Blood type correlates with egg reserve in infertile women
Chronic Disease

Betibeglogene autotemcel gene therapy effective for β-thalassemia

February 7, 2022
Non-invasive prenatal testing linked to decreased diagnostic testing
Gastroenterology

Lentiviral gene therapy treatment for adenosine deaminase deficiency

June 25, 2021
Chronic Disease

Recombinant viral vector treatment sustains endogenous factor IX activity in patients with hemophilia B

December 8, 2017
Next Post
PET scans in early-stage Hodgkin’s lymphoma may help guide therapy [RAPID trial]

PET scans in early-stage Hodgkin’s lymphoma may help guide therapy [RAPID trial]

Using adhesive strips with dermal sutures does not improve cosmesis

Using adhesive strips with dermal sutures does not improve cosmesis

Social integration may reduce suicide risk in male health professionals

Mindfulness-based cognitive therapy is not superior to maintenance antidepressants in preventing depression recurrence or relapse [PREVENT trial]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.